Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial ...
Members of the diplomatic community, business and industry representatives, the K92 Board of Directors, project partners and industry peers were also in attendance. As at September 30, 2025, 90% of ...
Third quarter revenues up 6% driven by EXPAREL volume growth of 9% -- -- Several key milestones advance 5x30 path to growth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback